🇺🇸 Iron isomaltoside in United States

191 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 36 reports (18.85%)
  2. Maternal Exposure During Pregnancy — 25 reports (13.09%)
  3. Bradycardia — 23 reports (12.04%)
  4. Hypotension — 20 reports (10.47%)
  5. Nausea — 20 reports (10.47%)
  6. Chest Discomfort — 14 reports (7.33%)
  7. Dizziness — 14 reports (7.33%)
  8. Chest Pain — 13 reports (6.81%)
  9. Off Label Use — 13 reports (6.81%)
  10. Pyrexia — 13 reports (6.81%)

Source database →

Other Hematology approved in United States

Frequently asked questions

Is Iron isomaltoside approved in United States?

Iron isomaltoside does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Iron isomaltoside in United States?

Thomas Jefferson University is the originator. The local marketing authorisation holder may differ — check the official source linked above.